Device type · LMG
Agent, Absorbable Hemostatic, Non-Collagen Based
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
LMG
General & Plastic Surgery
Device class
Class III
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
217
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Agent, Absorbable Hemostatic, Non-Collagen Based
- Product code
- LMG
- Device class
- Class III
- Review panel
- General & Plastic Surgery
- Regulation
- 21 CFR 878.4490
- Specialty
- General & Plastic Surgery, Wound Care
- FDA record
- Classification database entry for LMG
Latest FDA decisions
P210036 · Decided May 19, 2023 · 571 days after receipt
Device type: Agent, absorbable hemostatic, non-collagen based (LMG) · General & Plastic Surgery
Reports received
217
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
55
25% of reports
Injury reports
161
74% of reports
Death reports
1
0.5% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 3 | 10 | 0 | 0 |
| Jan 24 | 3 | 16 | 0 | 0 |
| Feb 24 | 13 | 7 | 1 | 0 |
| Mar 24 | 2 | 7 | 0 | 0 |
| Apr 24 | 8 | 19 | 0 | 0 |
| May 24 | 5 | 8 | 0 | 0 |
| Jun 24 | 19 | 13 | 0 | 0 |
| Jul 24 | 2 | 6 | 0 | 0 |
| Aug 24 | 20 | 4 | 0 | 0 |
| Sep 24 | 12 | 12 | 0 | 0 |
| Oct 24 | 0 | 11 | 0 | 0 |
| Nov 24 | 5 | 8 | 1 | 0 |
| Dec 24 | 5 | 26 | 0 | 0 |
| Jan 25 | 13 | 18 | 0 | 0 |
| Feb 25 | 2 | 2 | 0 | 0 |
| Mar 25 | 3 | 10 | 1 | 0 |
| Apr 25 | 11 | 27 | 2 | 0 |
| May 25 | 4 | 12 | 0 | 0 |
| Jun 25 | 4 | 10 | 0 | 0 |
| Jul 25 | 3 | 18 | 0 | 0 |
| Aug 25 | 8 | 11 | 0 | 0 |
| Sep 25 | 2 | 14 | 0 | 0 |
| Oct 25 | 8 | 17 | 0 | 0 |
| Nov 25 | 1 | 7 | 0 | 0 |
| Dec 25 | 11 | 11 | 0 | 0 |
| Jan 26 | 6 | 10 | 0 | 0 |
| Feb 26 | 4 | 2 | 0 | 0 |
| Mar 26 | 5 | 18 | 0 | 0 |
| Apr 26 | 5 | 22 | 0 | 0 |
| May 26 | 2 | 39 | 0 | 0 |
| Jun 26 | 2 | 21 | 1 | 0 |
| Jul 26 | 1 | 10 | 0 | 0 |
| Aug 26 | 4 | 5 | 0 | 0 |
| Sep 26 | 4 | 11 | 0 | 0 |
| Oct 26 | 10 | 5 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem155
- Device Contaminated During Manufacture or Shipping30
- Delivered as Unsterile Product7
- Device Markings/Labelling Problem7
- Patient-Device Incompatibility6
- Structural Problem6
- Failure to Degrade4
- Appropriate Device Problem Term/Code Not Available2
- Material Discolored2
- Device Contamination with Chemical or Other Material1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Unspecified Infection66
- No Clinical Signs, Symptoms or Conditions54
- Fever25
- Insufficient Information25
- Inflammation24
- Hemorrhage/Blood Loss/Bleeding17
- Pain17
- Abscess15
- Swelling/ Edema14
- Impaired Healing11
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Iron Deficiency Test (ferritin)Open, Classified
Z-0811-2026 · Started Nov 3, 2025 · Posted by FDA Dec 1, 2025
Reason given: Distribution without premarket approval/clearance.
Cause as FDA categorized it: No Marketing Application
- Melatonin TestOpen, Classified
Z-0812-2026 · Started Nov 3, 2025 · Posted by FDA Dec 1, 2025
Reason given: Distribution without premarket approval/clearance.
Cause as FDA categorized it: No Marketing Application
- SURGICEL FIBRILLAR 1INX2IN(2.5CMX5.1CM), Product Number: 1961Open, Classified
Ethicon Sarl, a Johnson & Johnson Company
Z-2406-2024 · Started Jun 11, 2024 · Posted by FDA Jul 17, 2024
Reason given: Some foil pouches were found torn open, impacting the sterile barrier which was traced to a specific machine used during product packaging.
Cause as FDA categorized it: Process control
- SURGICEL FIBRILLAR 1INX2IN(2.5CMX5.1CM), Product Number: 1963Open, Classified
Ethicon Sarl, a Johnson & Johnson Company
Z-2407-2024 · Started Jun 11, 2024 · Posted by FDA Jul 17, 2024
Reason given: Some foil pouches were found torn open, impacting the sterile barrier which was traced to a specific machine used during product packaging.
Cause as FDA categorized it: Process control
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.